share_log

Pediatrix Medical Group, Inc. (NYSE:MD) Given Average Recommendation of "Hold" by Brokerages

Defense World ·  Sep 4, 2022 06:11

Pediatrix Medical Group, Inc. (NYSE:MD – Get Rating) has been given a consensus recommendation of "Hold" by the eight analysts that are presently covering the stock, MarketBeat Ratings reports. Four research analysts have rated the stock with a hold recommendation and one has given a buy recommendation to the company. The average 1 year target price among analysts that have issued a report on the stock in the last year is $24.67.

Several research firms have recently commented on MD. BMO Capital Markets reduced their price target on Pediatrix Medical Group from $25.00 to $23.00 and set a "market perform" rating for the company in a research report on Wednesday, August 10th. Credit Suisse Group decreased their price target on shares of Pediatrix Medical Group from $30.00 to $28.00 and set an "outperform" rating for the company in a research report on Thursday, August 11th. Finally, Deutsche Bank Aktiengesellschaft cut their price objective on shares of Pediatrix Medical Group from $24.00 to $16.00 in a research report on Tuesday, May 10th.

Get Pediatrix Medical Group alerts:

Hedge Funds Weigh In On Pediatrix Medical Group

Several hedge funds have recently modified their holdings of MD. Envestnet Asset Management Inc. increased its holdings in shares of Pediatrix Medical Group by 4.2% in the fourth quarter. Envestnet Asset Management Inc. now owns 68,203 shares of the company's stock valued at $1,856,000 after purchasing an additional 2,739 shares during the period. Victory Capital Management Inc. raised its position in Pediatrix Medical Group by 77.2% during the 1st quarter. Victory Capital Management Inc. now owns 58,243 shares of the company's stock worth $1,079,000 after buying an additional 25,378 shares during the last quarter. Granite Investment Partners LLC lifted its stake in Pediatrix Medical Group by 3.5% during the 4th quarter. Granite Investment Partners LLC now owns 612,371 shares of the company's stock valued at $16,663,000 after acquiring an additional 20,599 shares during the period. Palisade Capital Management LLC NJ boosted its holdings in shares of Pediatrix Medical Group by 0.9% in the 4th quarter. Palisade Capital Management LLC NJ now owns 648,925 shares of the company's stock valued at $17,657,000 after acquiring an additional 5,770 shares during the last quarter. Finally, SG Americas Securities LLC increased its stake in shares of Pediatrix Medical Group by 403.5% in the fourth quarter. SG Americas Securities LLC now owns 36,806 shares of the company's stock worth $1,001,000 after acquiring an additional 29,496 shares during the period. Institutional investors and hedge funds own 95.98% of the company's stock.

Pediatrix Medical Group Stock Performance

MD stock opened at $17.45 on Friday. The company has a debt-to-equity ratio of 0.94, a current ratio of 1.39 and a quick ratio of 1.39. Pediatrix Medical Group has a 1-year low of $17.17 and a 1-year high of $31.72. The business has a 50-day moving average price of $21.35 and a 200 day moving average price of $21.47. The company has a market capitalization of $1.47 billion, a P/E ratio of 17.81, a PEG ratio of 1.13 and a beta of 1.84.

Pediatrix Medical Group (NYSE:MD – Get Rating) last announced its quarterly earnings results on Thursday, August 4th. The company reported $0.47 earnings per share for the quarter, topping the consensus estimate of $0.43 by $0.04. The firm had revenue of $486.00 million during the quarter, compared to analysts' expectations of $491.54 million. Pediatrix Medical Group had a net margin of 4.30% and a return on equity of 16.15%. The company's revenue was up 2.7% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.36 EPS. As a group, equities research analysts forecast that Pediatrix Medical Group will post 1.71 EPS for the current fiscal year.

About Pediatrix Medical Group

(Get Rating)

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States and Puerto Rico. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.

See Also

  • Get a free copy of the StockNews.com research report on Pediatrix Medical Group (MD)
  • Could Snap Stock Rebound As Management Restructures?
  • MarketBeat: Week in Review 8/29 – 9/2
  • Hormel Looks Cheap At These Levels
  • Lululemon Set To Soar Into September
  • Could Nike Stock be Oversold, but Still Overvalued?

Receive News & Ratings for Pediatrix Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediatrix Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment